Detalhe da pesquisa
1.
Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials.
J Infect Dis
; 228(6): 715-722, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202147
2.
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Lancet
; 395(10240): 1845-1854, 2020 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450106
3.
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 396(10249): 479-488, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702299
4.
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 389(10069): 621-628, 2017 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017399
5.
Long-term efficacy of a hepatitis E vaccine.
N Engl J Med
; 372(10): 914-22, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738667
6.
Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
Lancet
; 398(10317): 2134-2135, 2021 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774194
7.
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.
Lancet
; 385(9984): 2272-9, 2015 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25817373
8.
Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 386(10002): 1457-64, 2015 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26142048
9.
An epidemic of coxsackievirus B3 infection in infants and children in Jiangsu Province, China: a prospective cohort study.
Arch Virol
; 161(7): 1945-7, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27020571
10.
Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.
J Med Virol
; 87(12): 2009-17, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26010334
11.
Echovirus 7 associated with hand, foot, and mouth disease in mainland China has undergone a recombination event.
Arch Virol
; 160(5): 1291-5, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25680567
12.
Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
Int J Cancer
; 135(11): 2604-11, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740547
13.
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial.
Int J Cancer
; 135(11): 2612-22, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740596
14.
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
Lancet
; 381(9871): 1037-45, 2013 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23352749
15.
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 381(9882): 2024-32, 2013 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23726161
16.
Amino acid polymorphism in the reverse transcriptase region of hepatitis B virus and the relationship with nucleos(t)ide analogues treatment for preventing mother-to-infant transmission.
J Med Virol
; 86(8): 1288-95, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777553
17.
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
Lancet Infect Dis
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38614117
18.
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov.
Expert Rev Vaccines
; 22(1): 704-713, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37501516
19.
Comparison of antibody persistency through one year between one-dose and two-dose regimens of Ad5-nCoV vaccine for COVID-19.
Hum Vaccin Immunother
; 19(2): 2230760, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428653
20.
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial.
Lancet Infect Dis
; 23(10): 1143-1152, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352880